mRNA |
PD-0332991 |
CCLE |
pan-cancer |
AAC |
0.084 |
0.09 |
mRNA |
CAY10603 |
GDSC1000 |
pan-cancer |
AAC |
-0.053 |
0.09 |
mRNA |
MS-275 |
FIMM |
pan-cancer |
AAC |
0.23 |
0.09 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.09 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.09 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.09 |
mRNA |
CI-976 |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.09 |
mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
0.064 |
0.09 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.09 |
mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
0.056 |
0.09 |